Lankin, V., Tikhaze, A., Chazova, I., Viigimaa, M.

PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis

author

Lankin, Vadim Z.

Tikhaze, Alla K.

Chazova, Irina

Viigimaa, Margus

statement of authorship

Vadim Lankin, Alla Tikhaze, Irina Chazova, Margus Viigimaa

source

7th Baltic Atherosclerosis Society Congress : [abstracts]

location of publication

[Tallinn]

publisher

[Celsius Healthcare]

year of publication

2018

pages

p. 38-39

series

Eesti Arst ; vol. 97, 2018 : lisa

conference name, date

7th Baltic Atherosclerosis Society Congress, April 6-7, 2018

conference location

Tallinn, Estonia

url

http://www.ester.ee/record=b4819912*est

subject term

kolesterool

inhibiitorid

ateroskleroos

ISSN

0235-8026

TTÜ department

tervisetehnoloogiate instituut

language

inglise

Lankin, V., Tikhaze, A., Chazova, I., Viigimaa, M. PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis // 7th Baltic Atherosclerosis Society Congress : [abstracts]. [Tallinn] : [Celsius Healthcare], 2018. p. 38-39. (Eesti Arst ; vol. 97, 2018 : lisa). http://www.ester.ee/record=b4819912*est